Australia's most trusted
source of pharma news
Wednesday, 16 October 2024
Posted 16 October 2024 AM
Former Novartis Australia executive Michelle Parker has been promoted to CEO of Clarity Pharmaceuticals after six years at the ASX-listed radiopharmaceutical company.
Parker joined Clarity in 2018 after working at Novartis for a decade, starting as a Clinical Research Associate before quickly climbing the ranks to the position of Head of International Clinical Research Operations, which she held for four years.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.